Participants 0 97 4
The low-dose monoethylglycinexylidide test: assessment of liver function with fewer side effects.
Participants 379 463 4
subjects with normal (n = 5) and severely impaired liver function (n = 7) (study I).
Participants 1433 1642 3
The low-dose MEG-X test gives almost identical results to the standard MEG-X test and is associated with fewer side effects, which occur less often in individuals with more severely compromised liver function.
